ACGT, Inc. Accredited by the Clinical Laboratory Improvement Amendments (CLIA) Program

WHEELING, Ill.--(BUSINESS WIRE)--ACGT, Inc., a leading provider in Next Generation Sequencing (NGS), Sanger DNA sequencing and molecular biology services, announced today that its application for accreditation has been approved by the Clinical Laboratory Improvement Amendments (CLIA) Program. In connection with the company's recent accreditation by the College of American Pathologists (CAP), these credentials ensure that ACGT, Inc. has met the highest standards of excellence in quality laboratory practices. The CLIA and CAP accreditations come at a time when the company begins offering its services to the clinical research community.

Help employers find you! Check out all the jobs and post your resume.